These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15465999)

  • 1. Schizophrenia, syndrome X, and omega-3 fatty acids.
    Pouwer F; Lieverse R; Diamant M; Assies J
    Am J Psychiatry; 2004 Oct; 161(10):1926. PubMed ID: 15465999
    [No Abstract]   [Full Text] [Related]  

  • 2. Omega-3 fatty acid deficiency: a preventable risk factor for schizophrenia?
    McNamara RK
    Schizophr Res; 2011 Jul; 129(2-3):215-6. PubMed ID: 21276713
    [No Abstract]   [Full Text] [Related]  

  • 3. Are omega-3 fatty acids required for normal eye and brain development in the human?
    Uauy R
    J Pediatr Gastroenterol Nutr; 1990 Oct; 11(3):296-302. PubMed ID: 1978859
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of dietary fatty acids in the pathology of metabolic syndrome.
    Lottenberg AM; Afonso Mda S; Lavrador MS; Machado RM; Nakandakare ER
    J Nutr Biochem; 2012 Sep; 23(9):1027-40. PubMed ID: 22749135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Looking for the number-one omega-3. All three varieties are probably good for you, but evidence for the EPA and DHA in fish is the strongest.
    Harv Health Lett; 2003 Aug; 28(10):6. PubMed ID: 12936877
    [No Abstract]   [Full Text] [Related]  

  • 6. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.
    Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495
    [No Abstract]   [Full Text] [Related]  

  • 7. Nutrition and schizophrenia: beyond omega-3 fatty acids.
    Peet M
    Prostaglandins Leukot Essent Fatty Acids; 2004 Apr; 70(4):417-22. PubMed ID: 15041037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease.
    Monteiro J; Leslie M; Moghadasian MH; Arendt BM; Allard JP; Ma DW
    Food Funct; 2014 Mar; 5(3):426-35. PubMed ID: 24496399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal supplementation of long-chain polyunsaturated fatty acids, immune response and adult diseases.
    Das UN
    Med Sci Monit; 2004 May; 10(5):HY19-25. PubMed ID: 15114276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophrenia.
    Peet M
    Prostaglandins Leukot Essent Fatty Acids; 2006; 75(4-5):323-7. PubMed ID: 16934964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.
    Amminger GP; Mechelli A; Rice S; Kim SW; Klier CM; McNamara RK; Berk M; McGorry PD; Schäfer MR
    Transl Psychiatry; 2015 Jan; 5(1):e495. PubMed ID: 25585167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding.
    Horrobin DF; Jenkins K; Bennett CN; Christie WW
    Prostaglandins Leukot Essent Fatty Acids; 2002 Jan; 66(1):83-90. PubMed ID: 12051959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential fatty acids and the brain.
    Haag M
    Can J Psychiatry; 2003 Apr; 48(3):195-203. PubMed ID: 12728744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
    Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
    Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenic symptoms and dietary intake of n-3 fatty acids.
    Mellor JE; Laugharne JD; Peet M
    Schizophr Res; 1995 Dec; 18(1):85-6. PubMed ID: 8929766
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of Omega-3 Polyunsaturated Fatty Acids in the Treatment of Patients with Acute Respiratory Distress Syndrome: A Clinical Review.
    García de Acilu M; Leal S; Caralt B; Roca O; Sabater J; Masclans JR
    Biomed Res Int; 2015; 2015():653750. PubMed ID: 26339627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-6 and omega-3 essential fatty acids in atherosclerosis.
    Horrobin DF
    Semin Thromb Hemost; 1993; 19(2):129-37. PubMed ID: 8356458
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal supplementation with n-3 long chain polyunsaturated fatty acids during perinatal period alleviates the metabolic syndrome disturbances in adult hamster pups fed a high-fat diet after weaning.
    Kasbi-Chadli F; Boquien CY; Simard G; Ulmann L; Mimouni V; Leray V; Meynier A; Ferchaud-Roucher V; Champ M; Nguyen P; Ouguerram K
    J Nutr Biochem; 2014 Jul; 25(7):726-33. PubMed ID: 24767307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglycerides & omega-3s. Prescription omega-3 fatty acids are now among the hypertriglyceridemia therapies.
    Park NH
    Adv NPs PAs; 2010 Dec; 1(4):36-40. PubMed ID: 21319452
    [No Abstract]   [Full Text] [Related]  

  • 20. [Schizophrenia and omega 3 polyunsaturated fatty acids].
    Yoshikawa T
    Seishin Shinkeigaku Zasshi; 2009; 111(12):1531-6. PubMed ID: 20344881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.